Chongqing Pharscin Pharmaceutical Co., Ltd.

SZSE:002907 주식 보고서

시가총액: CN¥5.8b

Chongqing Pharscin Pharmaceutical 과거 수익 실적

과거 기준 확인 1/6

Chongqing Pharscin Pharmaceutical's earnings have been declining at an average annual rate of -24.1%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 3.3% per year. Chongqing Pharscin Pharmaceutical's return on equity is 3.8%, and it has net margins of 7.9%.

주요 정보

-24.1%

수익 성장률

-24.8%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률-3.3%
자기자본 수익률3.8%
순이익7.9%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) Popularity With Investors Is Under Threat From Overpricing

Oct 03
Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) Popularity With Investors Is Under Threat From Overpricing

Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) 30% Price Boost Is Out Of Tune With Revenues

Mar 06
Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) 30% Price Boost Is Out Of Tune With Revenues

수익 및 비용 분석

Chongqing Pharscin Pharmaceutical 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

SZSE:002907 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 247916330668
30 Jun 247493929375
31 Mar 247324328277
31 Dec 236923326278
30 Sep 237397028369
30 Jun 237788830167
31 Mar 237709929464
01 Jan 237859829659
30 Sep 227627529355
30 Jun 227788728746
31 Mar 228198529744
01 Jan 228469229742
30 Sep 2190311428439
30 Jun 2193911328240
31 Mar 2194212827338
31 Dec 2088211926836
30 Sep 2084012728233
30 Jun 2081614029730
31 Mar 2082116631524
31 Dec 1984217033426
30 Sep 1979616333122
30 Jun 1975616732718
31 Mar 1973013932320
31 Dec 1870313731615
30 Sep 1868613130913
30 Jun 1866112829315
31 Mar 1863112028810
31 Dec 175921122709
30 Sep 176021122684
31 Dec 16552962490
31 Dec 15469742050
31 Dec 14426592030

양질의 수익: 002907 has high quality earnings.

이익 마진 증가: 002907's current net profit margins (7.9%) are lower than last year (9.5%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: 002907's earnings have declined by 24.1% per year over the past 5 years.

성장 가속화: 002907's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

수익 대 산업: 002907 had negative earnings growth (-11.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-1.2%).

자기자본 수익률

높은 ROE: 002907's Return on Equity (3.8%) is considered low.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y